review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1042020459 |
P356 | DOI | 10.1186/2046-4053-2-20 |
P953 | full work available at URL | http://link.springer.com/article/10.1186/2046-4053-2-20/fulltext.html |
http://link.springer.com/content/pdf/10.1186/2046-4053-2-20 | ||
http://link.springer.com/content/pdf/10.1186/2046-4053-2-20.pdf | ||
https://europepmc.org/articles/PMC3651267 | ||
https://europepmc.org/articles/PMC3651267?pdf=render | ||
https://systematicreviewsjournal.biomedcentral.com/track/pdf/10.1186/2046-4053-2-20 | ||
P932 | PMC publication ID | 3651267 |
P698 | PubMed publication ID | 23566447 |
P5875 | ResearchGate publication ID | 236138000 |
P2093 | author name string | Rob M. Baltussen | |
Sten G. Zelle | |||
P2860 | cites work | Low cost of cancer detection in the first year of mammographic screening in Poland | Q51853795 |
Retrospective cost-effectiveness analysis of screening mammography | Q53241570 | ||
Screening for breast cancer | Q69223355 | ||
International trends in the economics of breast examination | Q70224657 | ||
Cost of diseases in Brazil: breast cancer, enteritis, cardiac valve disease and bronchopneumonia | Q71325040 | ||
Comparison of three instruments assessing the quality of economic evaluations: a practical exercise on economic evaluations of the surgical treatment of obesity | Q81581720 | ||
The good news about cancer in developing countries | Q82354160 | ||
Screening for breast cancer in Iran: a challenge for health policy makers | Q82561162 | ||
Breast screening: the facts--or maybe not | Q83251265 | ||
Cytopathology Including Fine-Needle Aspiration in Sub-Saharan Africa: A Cameroon Experience | Q83338540 | ||
Expenditure audit of women with breast cancer in a tertiary care hospital of Delhi | Q83368809 | ||
Methodological issues in cost-effectiveness studies: a brief overview | Q83471199 | ||
Resource-sparing and cost-effective strategies in current management of breast cancer | Q84097261 | ||
Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England | Q24629668 | ||
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control | Q30485941 | ||
Cost-effective screening for breast cancer worldwide: current state and future directions | Q30488485 | ||
Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data | Q33779753 | ||
A tool to improve quality of reporting published economic analyses | Q33920992 | ||
Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database | Q34061266 | ||
Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco | Q34142012 | ||
Priority actions for the non-communicable disease crisis | Q34176583 | ||
Breast Cancer: A Neglected Disease for the Majority of Affected Women Worldwide | Q34949553 | ||
Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis | Q35798038 | ||
Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study | Q35798048 | ||
Generalisability in economic evaluation studies in healthcare: a review and case studies. | Q35950554 | ||
Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report | Q36263674 | ||
Bias in clinical intervention research. | Q36380552 | ||
Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party | Q36599584 | ||
The burden and costs of chronic diseases in low-income and middle-income countries | Q37026095 | ||
Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative | Q37849954 | ||
Establishing an evidence-base for breast cancer control in developing countries | Q37858212 | ||
Breast cancer early detection methods for low and middle income countries, a review of the evidence | Q37979916 | ||
Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. | Q38423916 | ||
Cost-effectiveness of clinical breast assessment-based screening in rural Egypt. | Q38970025 | ||
The costs of breast cancer prior to and following diagnosis | Q39889963 | ||
Continuing declines in cancer mortality in the European Union | Q40260959 | ||
Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: doxorubicin plus cyclophosphamide versus docetaxel plus cyclophosphamide. | Q43267099 | ||
Cost-effectiveness of anastrozole, in comparison with tamoxifen, in the adjuvant treatment of early breast cancer in Brazil | Q43277240 | ||
Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer | Q43993886 | ||
Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India | Q44067048 | ||
Cost-utility analysis of adjuvant therapies for breast cancer in Iran. | Q44401570 | ||
Economic evaluation of radiotherapy for early breast cancer after breast-conserving surgery in a health resource-limited setting | Q44878875 | ||
Breast and Prostate Cancer Productivity Costs: A Comparison of the Human Capital Approach and the Friction Cost Approach | Q45951626 | ||
The Cost-effectiveness of Mammographic Screening Strategies | Q46242452 | ||
Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia | Q46573606 | ||
Mammographic Screening and “Overdiagnosis” | Q46683429 | ||
Fine needle aspiration (FNA) in the management of palpable masses in Ibadan: impact on the cost of care | Q46800453 | ||
Costs, effects and cost-effectiveness of breast cancer control in Ghana | Q47371218 | ||
Marking non-palpable breast masses with injected methylene blue dye, an easy, safe and low cost method for developing countries and resource-limited areas | Q48235390 | ||
Breast cancer screening; cost-effective in practice? | Q50139380 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | global health | Q2725393 |
breast neoplasm | Q23929670 | ||
mass screening | Q64733553 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 20 | |
P577 | publication date | 2013-04-08 | |
P13046 | publication type of scholarly work | systematic review | Q1504425 |
P1433 | published in | Systematic Reviews | Q18216009 |
P1476 | title | Economic analyses of breast cancer control in low- and middle-income countries: a systematic review | |
P478 | volume | 2 |
Q36036440 | A Systematic Review of Health Economic Analyses of Housing Improvement Interventions and Insecticide-Treated Bednets in the Home |
Q27005964 | A review of systematic reviews of the cost-effectiveness of hormone therapy, chemotherapy, and targeted therapy for breast cancer |
Q41486867 | Cancer control capacity in 50 low- and middle-income countries |
Q89967674 | Cost-Effectiveness of Lifestyle-Related Interventions for the Primary Prevention of Breast Cancer: A Rapid Review |
Q35070383 | Cost-effectiveness analysis of breast cancer control interventions in Peru |
Q26795628 | Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries |
Q27013654 | Implementation science in cancer prevention and control: a framework for research and programs in low- and middle-income countries |
Q46928725 | Improving women's health in low-income and middle-income countries. Part II: the needs of diagnostic imaging. |
Q43866899 | Predicting the stage shift as a result of breast cancer screening in low- and middle-income countries: a proof of concept |
Q27027277 | Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal |
Q36270293 | Refining a questionnaire to assess breast cancer knowledge and barriers to screening in Kenya: Psychometric assessment of the BCAM. |
Q35665603 | Systematic Review and Quality Appraisal of Economic Evaluation Publications in Dentistry |
Q90377048 | Systematic reviews as a "lens of evidence": Determinants of cost-effectiveness of breast cancer screening |
Search more.